<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="case-report" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">BMC Med Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">BMC Med. Genet</journal-id>
<journal-title-group>
<journal-title>BMC Medical Genetics</journal-title>
</journal-title-group>
<issn pub-type="epub">1471-2350</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30144815</article-id>
<article-id pub-id-type="pmc">6109285</article-id>
<article-id pub-id-type="publisher-id">669</article-id>
<article-id pub-id-type="doi">10.1186/s12881-018-0669-7</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A novel <italic>MFSD8</italic> mutation in a Russian patient with neuronal ceroid lipofuscinosis type 7: a case report</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Kozina</surname>
<given-names>Anastasiya Aleksandrovna</given-names>
</name>
<address>
<email>doctor@genotek.ru</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Okuneva</surname>
<given-names>Elena Grigorievna</given-names>
</name>
<address>
<email>egokuneva@genotek.ru</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Baryshnikova</surname>
<given-names>Natalia Vladimirovna</given-names>
</name>
<address>
<email>nbaryshnik73@yandex.ru</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Krasnenko</surname>
<given-names>Anna Yurievna</given-names>
</name>
<address>
<email>krasnenko@genotek.ru</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tsukanov</surname>
<given-names>Kirill Yurievich</given-names>
</name>
<address>
<email>tsukanof@genotek.ru</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Klimchuk</surname>
<given-names>Olesya Igorevna</given-names>
</name>
<address>
<email>klimchuk@genotek.ru</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kondakova</surname>
<given-names>Olga Borisovna</given-names>
</name>
<address>
<email>kondakovao68@gmail.com</email>
</address>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Larionova</surname>
<given-names>Anna Nikolaevna</given-names>
</name>
<address>
<email>annalario21@yandex.ru</email>
</address>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Batysheva</surname>
<given-names>Tatyana Timofeevna</given-names>
</name>
<address>
<email>detb18@mail.ru</email>
</address>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9414-4202</contrib-id>
<name>
<surname>Surkova</surname>
<given-names>Ekaterina Ivanovna</given-names>
</name>
<address>
<email>esurkova@genotek.ru</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shatalov</surname>
<given-names>Peter Alekseevich</given-names>
</name>
<address>
<email>peter@genotek.ru</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ilinsky</surname>
<given-names>Valery Vladimirovich</given-names>
</name>
<address>
<email>valery@genotek.ru</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
<xref ref-type="aff" rid="Aff6">6</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 8607 342X</institution-id><institution-id institution-id-type="GRID">grid.418846.7</institution-id><institution>Institute of Biomedical Chemistry, </institution></institution-wrap>Pogodinskaya street 10 building 8, 119121 Moscow, Russia </aff>
<aff id="Aff2"><label>2</label>Genotek Ltd, Nastavnicheskii pereulok 17/1, 105120 Moscow, Russia </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9559 0613</institution-id><institution-id institution-id-type="GRID">grid.78028.35</institution-id><institution>Pirogov Russian National Research Medical University, </institution></institution-wrap>Ostrovitianova street 1, 117997 Moscow, Russia </aff>
<aff id="Aff4"><label>4</label>Scientific and Practical Centre of Pediatric psychoneurology of Moscow Healthcare Department, Michurinsky prospect, 74, 119602 Moscow, Russia </aff>
<aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9559 0613</institution-id><institution-id institution-id-type="GRID">grid.78028.35</institution-id><institution>Veltischev Research and Clinical Institute for Pediatrics of the Pirogov Russian National Research Medical University, </institution></institution-wrap>Taldomskaya str 2, 125412 Moscow, Russia </aff>
<aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0404 8765</institution-id><institution-id institution-id-type="GRID">grid.433823.d</institution-id><institution>Vavilov Institute of General Genetics, </institution></institution-wrap>Gubkina street 3, 119333 Moscow, Russia </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>25</day>
<month>8</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>25</day>
<month>8</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>19</volume>
<elocation-id>151</elocation-id>
<history>
<date date-type="received">
<day>1</day>
<month>6</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>8</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s). 2018</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<sec>
<title>Background</title>
<p id="Par1">Neuronal ceroid lipofuscinoses (NCLs) are the most common autosomal recessive neurodegenerative disorders in children. Clinical manifestations include progressive cognitive decline, motor impairment, ataxia, visual loss, seizures and early death. To date more than 440 NCL-causing mutations in 13 genes are known.</p>
</sec>
<sec>
<title>Case presentation</title>
<p id="Par2">We report clinical and genetic characteristics of a 5-year-old girl affected by ceroid lipofuscinosis type 7 (NCL7). She had progressive motor and mental deterioration since the age of 2,5 years. Later she developed progressive vision loss, stereotypies, action myoclonus and epilepsy. By the age of 5 years she stopped walking. Based on symptoms, diagnosis of Rett syndrome was suggested, but no abnormalities were detected in <italic>MeCP2.</italic> We identified a novel homozygous mutation in <italic>MFSD8</italic> gene (c.525 T &gt; A, p.Cys175Ter). To our knowledge, this is the first report of <italic>MFSD8</italic> gene mutation in a Russian patient with variant late-infantile NCL.</p>
</sec>
<sec>
<title>Conclusions</title>
<p id="Par3">Our results enlarge mutational spectrum of ceroid lipofuscinosis type 7 and demonstrate tremendous diagnosis value of exome sequencing for pediatric NCLs. Also we confirmed that NCL should be suspected in patients with Rett-like phenotype at onset and negative <italic>MECP2</italic> mutation.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Neuronal ceroid lipofuscinosis</kwd>
<kwd>NCL</kwd>
<kwd>
<italic>MFSD8</italic>
</kwd>
<kwd>NCL7</kwd>
<kwd>Variant late-infantile NCL</kwd>
<kwd>Rett-like phenotype</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002674</institution-id>
<institution>Russian Academy of Sciences</institution>
</institution-wrap>
</funding-source>
<award-id>Fundamental Scientific Program 2013-2020</award-id>
<principal-award-recipient>
<name>
<surname>Kozina</surname>
<given-names>Anastasiya Aleksandrovna</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Background</title>
<p id="Par10">Neuronal ceroid lipofuscinoses (NCLs), also known as Batten disease, are a group of autosomal recessive lysosomal storage diseases. Autosomal dominant inheritance has been reported in one adult-onset form [<xref ref-type="bibr" rid="CR1">1</xref>]. NCL is the most common of neurodegenerative disorders of childhood with prevalence up to 1:14,000 worldwide [<xref ref-type="bibr" rid="CR2">2</xref>]. NCLs are associated with progressive loss of cognitive and motor skills, seizures, myoclonus, loss of vision, and usually reduced life expectancy. The age of onset can be variable. Almost all NCL patients had accumulation of autofluorescent lipopigment in lysosomes of neurons and other cell types. This storage process is associated with selective destruction and loss of neurons in brain and retina. The ultrasructure of the storage deposits varies between different forms of NCL [<xref ref-type="bibr" rid="CR3">3</xref>].</p>
<p id="Par11">Previously, NCL classification was based on age of onset together with clinical presentation. Patients were grouped in one of four basic NCL types: infantile, late infantile, juvenile and adult [<xref ref-type="bibr" rid="CR4">4</xref>].</p>
<p id="Par12">To date more than 440 NCL-causing mutations in 13 genes are known [<xref ref-type="bibr" rid="CR5">5</xref>]. The new classification structured in 7 diagnostic axes: responsible gene, precise genetic defect, clinical characteristics (age at onset, presenting symptoms, disease progression), biochemical phenotype, ultrastructural features, functionality and other remarks [<xref ref-type="bibr" rid="CR6">6</xref>]. But a direct correlation between the gene that is mutated and phenotype does not always exist [<xref ref-type="bibr" rid="CR7">7</xref>].</p>
<p id="Par13">Within late infantile NCLs, several types with discreet different clinical characteristics are described and separated into variant late infantile NCL (vLINCL). vLINCLs are genetically heterogeneous forms with four major disease-causing genes: <italic>CLN5</italic>, <italic>CLN6</italic>, <italic>CLN7</italic> (<italic>MFSD8</italic>), <italic>CLN8</italic>. Homozygous or compound heterozygous mutations in <italic>MFSD8</italic> were previously reported to cause vLINCL called NCL7 disease (OMIM 610951). <italic>MFSD8</italic> gene (OMIM 611124) encodes CLN7, a putative lysosomal transporter protein [<xref ref-type="bibr" rid="CR8">8</xref>].</p>
<p id="Par14">NCL7 form was first described in children from Turkey: Topcu with colleagues evaluated clinical and histopathologic features of 36 Turkish patients with late-infantile NCL [<xref ref-type="bibr" rid="CR9">9</xref>]. This form was considered a distinct clinical and genetic variant of NCL, but later studies showed that NCL7 disease is not limited to Turkish population [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. It is now evident that Turkish vLINCL is genetically very heterogeneous with mutation in three genes: <italic>CLN6</italic> [<xref ref-type="bibr" rid="CR12">12</xref>], <italic>CLN8</italic> [<xref ref-type="bibr" rid="CR13">13</xref>] and <italic>MFSD8</italic> [<xref ref-type="bibr" rid="CR14">14</xref>]. Clinical phenotype of patients with different variants of infantile and late infantile NCLs is quite uniform. However, Rett-like onset have been described for NCL7 disease, produced by <italic>MFSD8</italic> gene mutations, and infantile NCL1 disease [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. Similar autistic characteristics and stereotypic movements were observed in several forms of NCL [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>].</p>
<p id="Par15">In this study we analyzed clinical and genetic characteristics of a 5-year-old girl with cognitive and motor deterioration, vision loss, stereotypies, action myoclonus and epilepsy.</p>
</sec>
<sec id="Sec2">
<title>Case presentation</title>
<p id="Par16">The patient was a 5 year-old girl from Russia. She had unremarkable perinatal, neonatal and family history (parents and brother are clinically healthy).</p>
<p id="Par17">She was born from the fifth pregnancy, the second childbirth and was delivered by Caesarean section. Her birth weight was 3800 g and height was 53 cm. Apgar scores were 8 and 8 at 1 and 5 min respectively. No abnormalities were noted in neonatal period. Up to 2.5 years the girl developed according to her age without delay of speech and motor development. At the age of 2,5 years against a background of trauma of little finger, girl stopped talking. Gradually speech was restored, but vocabulary decreased. At 3 years the first febrile seizure attack occurred. Later parents noticed significant deterioration in her speech and communication. She became socially withdrawn. Brain magnetic resonance imaging revealed diffuse lesions in the white matter and hypoplasia of the lower cerebellar vermis. At the age of 3, 5 years stereotypic movements appeared. From 3, 5 years patient was commenced on valproic acid (antiepileptic drug). But motor deterioration progressed: by the age of 5 she stopped walking.</p>
<p id="Par18">Based on observed symptoms, diagnosis of Rett syndrome was suggested. Prior to clinical exome sequencing the following studies were carried out: measurement of palmitoyl protein thioesterase (PPT) level in leukocyte, tandem mass spectroscopy, sequencing of <italic>MeCP2</italic> and <italic>TPP1</italic>, analysis of common mitochondrial DNA mutations. All studies showed no abnormalities.</p>
<p id="Par19">At the age of 5 years 8 months she was admitted to Scientific and Practical Center of Pediatric Psychoneurology with motor and mental deterioration, visual impairment and stereotypies.</p>
<p id="Par20">She had normal physical development: she was 20, 5 kg in weight and 111 cm in height. Head was normal shape, head circumference was 50, 5 cm (normal). The skin was normal and clean. Abdomen was soft, painless. Stool and micturition were normal. Basic blood and urine tests were normal.</p>
<p id="Par21">There was no interest in environment, no play activity. Orientation in space and time was absent. Speech and understanding of speech is disturbed: she used only speech sounds and syllables. She had stereotypic movements of hands and face. The girl have myoclonus in her hands, legs and facial muscles. Tactile stimulation enhances myoclonus. She does not walk, does not stand, does not crawl. A girl can only hold her head, roll over, sit with periodic falls.</p>
<p id="Par22">Ophthalmological evaluation revealed partial atrophy of optic nerves, nistagmus, retinitis pigmentosa and mixed astigmatism.</p>
<p id="Par23">EEG (electroencephalography) revealed a significant delay in the formation of cortical electrogenesis and poorly-structured epileptiform activity in the occipital-parietal-posterior temporal regions.</p>
<p id="Par24">MRI (Magnetic Resonance Imaging) revealed cortical atrophy, periventricular leukopathy of both hemispheres of the brain and atrophy of the cerebellum (Fig. <xref ref-type="fig" rid="Fig1">1</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p>Brain MRI of 5-year-old girl with NCL7. <bold>a</bold>. Diffuse cortical atrophy, increased intensity of the MR signal in periventricular white matter. Axial T2 weighted FLAIR image. <bold>b</bold>. Diffuse cortical and subcortical atrophy of the brain. Axial T1 weighted image. <bold>c</bold>. Atrophy of the cerebellum, cortical atrophy of the brain. Sagittal T1 weighted image. <bold>d</bold>. Diffuse cortical and subcortical atrophy of the brain, atrophy of the cerebellum. Frontal T1 weighted image</p></caption><graphic id="MO1" xlink:href="12881_2018_669_Fig1_HTML"></graphic></fig></p>
<p id="Par25">ECG (electrocardiography) showed severe sinus bradyarrhythmia. The heart rate was 48–84 bpm.</p>
<p id="Par26">In the hospital, she received treatment with anticonvulsant drugs: topiramate (100 mg/day) and levetiracetam (1200 mg/day).</p>
<p id="Par27">Clinical exome sequencing was carried out by Genotek Ltd. Genomic DNA from peripheral blood sample was extracted using QIAamp DNA Mini Kit (Qiagen) according to manufacturerʼs protocol. DNA libraries were prepared using AmpliSeq Exome (ThermoFisher Scientific) according to manufacturerʼs protocol. Sequencing was performed on Ion Proton System (ThermoFisher Scientific). After sequencing we trimmed 3′-nucleotides with read quality below 10 using Cutadapt [<xref ref-type="bibr" rid="CR19">19</xref>]. Raw reads were aligned to reference genome hg19 (GRCh37.p13) using BWA MEM [<xref ref-type="bibr" rid="CR20">20</xref>]. FastQС was used for data quality control [<xref ref-type="bibr" rid="CR21">21</xref>]. We called short variants using GATK HaplotypeCaller [<xref ref-type="bibr" rid="CR22">22</xref>] according to GATK Best Practices DNA-seq [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>]. The effect of each mutation was assessed using snpEff [<xref ref-type="bibr" rid="CR25">25</xref>] To assess pathogenicity and conservatism, the data was extracted from the dbNSFP [<xref ref-type="bibr" rid="CR26">26</xref>], Clinvar [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR28">28</xref>], OMIM database (Online Mendelian Inheritance in Man) [<xref ref-type="bibr" rid="CR29">29</xref>] and HGMD [<xref ref-type="bibr" rid="CR30">30</xref>], as well as using the SIFT [<xref ref-type="bibr" rid="CR31">31</xref>] and PolyPhen-2 [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR33">33</xref>] utilities to predict pathogenicity of the mutation. Information on the frequency of mutations was taken from 1000Genomes project [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR35">35</xref>], ExAC [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>] and Genotek frequency data. Description of mutations and their pathogenicity were predicted according to the Standards and Guidelines developed by ACMG (American College of Medical Genetics and Genomics), AMP (Association for Molecular Pathology) and CAP (College of American Pathologists) [<xref ref-type="bibr" rid="CR38">38</xref>]. Copy number alterations were determined using CNVkit [<xref ref-type="bibr" rid="CR39">39</xref>].</p>
<p id="Par28"><italic>MFSD8</italic> variant identified by exome sequencing was confirmed by Sanger sequencing.</p>
</sec>
<sec id="Sec3">
<title>Discussion and conclusions</title>
<p id="Par29">In this article we described a case of 5-year old girl with motor and mental deterioration, progressive vision loss, stereotypies, action myoclonus and epilepsy. Disease had Rett-like onset (psychomotor regression, stereotypic hands movements). Therefore, prior to clinical exome sequencing Rett syndrome was excluded by analysis of <italic>MeCP2.</italic> Also analysis of frequent mutations and biochemical indices was performed for several diseases: aminoacidopathies, organic aciduria, NCL1, NCL2, mitochondrial fatty acid betta-oxidation disorders, MELAS (mitochondrial encephalopathy, lactic acidosis and stroke-like episodes), MERRF syndrome (myoclonic epilepsy with ragged red fibers), NARP (neuropathy, ataxia, and retinitis pigmentosa). All results were negative.</p>
<p id="Par30">Exome sequencing revealed homozygous c.525 T &gt; A variant in exon 6 of the <italic>MFSD8</italic> (NM_152778.2). This variant leads to a premature stop codon (p.Cys175Ter). This homozygous mutation was confirmed by Sаnger sequencing (Fig. <xref ref-type="fig" rid="Fig2">2</xref>).<fig id="Fig2"><label>Fig. 2</label><caption><p>Electrophoregram from Sanger sequencing of the proband showing the homozygous c.525 T &gt; A change in exon 6 of <italic>MFSD8</italic>, which predicts a p.Cys175Ter change</p></caption><graphic id="MO2" xlink:href="12881_2018_669_Fig2_HTML"></graphic></fig></p>
<p id="Par31">This mutation is not reported in 60,706 subjects in ExAC [<xref ref-type="bibr" rid="CR34">34</xref>] or in 2535 subjects in 1000 Genomes Browser [<xref ref-type="bibr" rid="CR32">32</xref>]. This mutation was not found in our 2000 in-house exomes.</p>
<p id="Par32">Discovered variant was predicted to be pathogenic. This variant affects 175 aa of protein in transmembrane ɑ helix. This nonsense variant may result in truncated protein that is nonfunctional or leads to degradation of mRNA through nonsense-mediated decay [<xref ref-type="bibr" rid="CR40">40</xref>].</p>
<p id="Par33">This mutation was not described previously, but homozygous or compound heterozygous mutations in this gene are associated with ceroid lipofuscinosis. To date, 38 mutations in <italic>MFSD8</italic> were described previously, most being homozygous missense mutations [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR11">11</xref>]. This mutations predominantly lead to NCL7 disease - subtype of vLINCL form. Phenotypes of almost all affected individuals are very similar regardless of mutation type [<xref ref-type="bibr" rid="CR41">41</xref>].</p>
<p id="Par34">The symptoms of NCL7 disease typically begin between ages 2 and 11 (mean onset 5 years). The initial features usually include seizures and the loss of previously acquired skills. As the disease progressed, mental regression, myoclonus, speech impairment, loss of vision developed [<xref ref-type="bibr" rid="CR15">15</xref>].</p>
<p id="Par35"><italic>MFSD8</italic> gene, which is located on chromosome 4q28.1-q28.2, encodes CLN7, a putative lysosomal transporter with suggested topology of 12 transmembrane domains that was shown to be localized to the lysosomal membrane and belongs to the major facilitator superfamily (MFS). These proteins are single-polypeptide carriers that are able to transport small solutes by using chemiosmotic ion gradients [<xref ref-type="bibr" rid="CR42">42</xref>]. Specific molecules that MFSD8 transports across the lysosomal membrane have not been identified. Although this protein is ubiquitously expressed, high transcript concentrations have been identified in several brain locations, such as cerebellar cortex and hippocampus [<xref ref-type="bibr" rid="CR43">43</xref>].</p>
<p id="Par36">Despite advances in diagnosis of neurodegenerative disorders, NCLs remain a challenge for pediatric neurologists, because clinical signs in young children or toddlers are subtle and often overlap with other congenital neurodegenerative diseases, such as mitochondrial disorders, Rett syndrome or early-onset Parkinsonism. Craiu with colleagues concluded that NCL should be suspected in patients with Rett-like phenotype at onset and negative <italic>MECP2</italic> mutation [<xref ref-type="bibr" rid="CR15">15</xref>]. Disease of our patient also had Rett-like signs at onset which caused diagnostic delay. Both Rett syndrome and NCLs usually have normal development until age 9–24 months. Patient in Craiu et al. article has NCL7 disease with Rett-like onset at 18 months. Our case has late manifestation at 2,5 years which made it more difficult to diagnose. Increase in genetic understanding of NCLs has led to improved diagnostic approaches. Our study revealed that early ophthalmological examination of patients with motor and mental regression can be useful for diagnosis.</p>
<p id="Par37">Although there is no treatment for this condition, correct and early diagnosis is important for appropriate low-vision management, educational planning, and genetic counseling.</p>
<p id="Par38">This report describes the first case of NCL7 disease in Russia. Our findings expanded variant diversity of <italic>MFSD8</italic> and proved value of exome sequencing for pediatric NCLs.</p>
</sec>
</body>
<back>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>ACMG</term>
<def>
<p id="Par4">American College of Medical Genetics and Genomics</p>
</def>
</def-item>
<def-item>
<term>ECG</term>
<def>
<p id="Par5">Electrocardiography</p>
</def>
</def-item>
<def-item>
<term>EEG</term>
<def>
<p id="Par6">Electroencephalography</p>
</def>
</def-item>
<def-item>
<term>MRI</term>
<def>
<p id="Par7">Magnetic Resonance Imaging</p>
</def>
</def-item>
<def-item>
<term>NCL</term>
<def>
<p id="Par8">Neuronal Ceroid Lipofuscinosis</p>
</def>
</def-item>
<def-item>
<term>NGS</term>
<def>
<p id="Par9">Next Generation Sequencing</p>
</def>
</def-item>
</def-list>
</glossary>
<ack>
<title>Acknowledgements</title>
<p>We sincerely thank all the family members who contributed to the study.</p>
<sec id="FPar1">
<title>Funding</title>
<p id="Par39">Analysis and interpretation of data were carried out with financial support from the Fundamental Scientific Research Program of the Russian Academy of Sciences for 2013–2020.</p>
</sec>
<sec id="FPar2">
<title>Availability of data and materials</title>
<p id="Par40">We did not use new software, databases, or applications/tools in the manuscript, and our raw data has already described in the manuscript and figures. Data of this study was submitted in ClinVar.</p>
</sec>
</ack>
<notes notes-type="author-contribution">
<title>Authors’ contributions</title>
<p>AA, EG, NV, AYu, KYu, OI, OB, AN, TT, EI, PA, VV met the International Committee of Medical Journal Editors (ICMJE) criteria for authorship. AA, EG, NV, EI and PA contributed to data collection and the first draft of the manuscript. AYu, KYu and OI carried out the mutation analysis. OB, AN and TT cared for the patient. VV was a mentor who contributed equally to this work. All authors read and approved the final manuscript.</p>
</notes>
<notes notes-type="COI-statement">
<sec id="FPar3">
<title>Ethics approval and consent to participate</title>
<p>All research was approved by the ethics committee of Genotek Ltd. (04/2018). The patient’s parents have provided written informed consent.</p>
</sec>
<sec id="FPar4">
<title>Consent for publication</title>
<p>The patient’s parents gave written informed consent to studies and publication of clinical information, images and sequencing data.</p>
</sec>
<sec id="FPar5">
<title>Competing interests</title>
<p>AA, EG, NV, AYu, KYu, OI, EI, PA, VV are employees of Genotek Ltd. The authors declare that they have no other competing interests.</p>
</sec>
<sec id="FPar6">
<title>Publisher’s Note</title>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</sec>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nosková</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Stránecký</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Hartmannová</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Přistoupilová</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Barešová</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Ivánek</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutations in DNAJC5, encoding cysteine-string protein alpha, cause autosomal-dominant adult-onset neuronal ceroid lipofuscinosis</article-title>
<source/>Am J Hum Genet
          <year>2011</year>
<volume>89</volume>
<issue>2</issue>
<fpage>241</fpage>
<lpage>252</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2011.07.003</pub-id>
<pub-id pub-id-type="pmid">21820099</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haltia</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Goebel</surname>
<given-names>HH</given-names>
</name>
</person-group>
<article-title>The neuronal ceroid-lipofuscinoses: a historical introduction</article-title>
<source/>Biochim Biophys Acta
          <year>2013</year>
<volume>1832</volume>
<issue>11</issue>
<fpage>1795</fpage>
<lpage>1800</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbadis.2012.08.012</pub-id>
<pub-id pub-id-type="pmid">22959893</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haltia</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>The neuronal ceroid-lipofuscinoses</article-title>
<source/>J Neuropathol Exp Neurol
          <year>2003</year>
<volume>62</volume>
<issue>1</issue>
<fpage>1</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="doi">10.1093/jnen/62.1.1</pub-id>
<pub-id pub-id-type="pmid">12528813</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Mole</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Goebel</surname>
<given-names>HH</given-names>
</name>
</person-group>
<source/>The neuronal ceroid Lipofuscinoses (batten disease)
          <year>2011</year>
<publisher-loc>Oxford</publisher-loc>
<publisher-name>Oxford University Press</publisher-name>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<mixed-citation publication-type="other">NCL mutation and patient Database <ext-link ext-link-type="uri" xlink:href="https://www.ucl.ac.uk/ncl/mutation.shtml">https://www.ucl.ac.uk/ncl/mutation.shtml</ext-link>. Accessed 1 June 2018.</mixed-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Williams</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Mole</surname>
<given-names>SE</given-names>
</name>
</person-group>
<article-title>New nomenclature and classification scheme for the neuronal ceroid lipofuscinoses</article-title>
<source/>Neurology
          <year>2012</year>
<volume>79</volume>
<issue>2</issue>
<fpage>183</fpage>
<lpage>191</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.0b013e31825f0547</pub-id>
<pub-id pub-id-type="pmid">22778232</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Mole</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>RE</given-names>
</name>
</person-group>
<person-group person-group-type="editor">
<name>
<surname>Adam</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Ardinger</surname>
<given-names>HH</given-names>
</name>
<name>
<surname>Pagon</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Wallace</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>LJH</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Stephens</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Amemiya</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Neuronal Ceroid-Lipofuscinoses</article-title>
<source/>GeneReviews®
          <year>2001</year>
<publisher-loc>Seattle (WA)</publisher-loc>
<publisher-name>University of Washington, Seattle</publisher-name>
<fpage>1993</fpage>
<lpage>2018</lpage>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siintola</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Topcu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Aula</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Lohi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Minassian</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Paterson</surname>
<given-names>AD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The novel neuronal ceroid lipofuscinosis gene MFSD8 encodes a putative lysosomal transporter</article-title>
<source/>Am J Hum Genet
          <year>2007</year>
<volume>81</volume>
<issue>1</issue>
<fpage>136</fpage>
<lpage>146</lpage>
<pub-id pub-id-type="doi">10.1086/518902</pub-id>
<pub-id pub-id-type="pmid">17564970</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Topçu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Yalnizoğlu</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Usubütün</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Saatçi</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Aynaci</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Evaluation of 36 patients from Turkey with neuronal ceroid lipofuscinosis: clinical, neurophysiological, neuroradiological and histopathologic studies</article-title>
<source/>Turk J Pediatr
          <year>2004</year>
<volume>46</volume>
<issue>1</issue>
<fpage>1</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="pmid">15074367</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kousi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Siintola</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Dvorakova</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Vlaskova</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Turnbull</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Topcu</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutations in CLN7/MFSD8 are a common cause of variant late-infantile neuronal ceroid lipofuscinosis</article-title>
<source/>Brain
          <year>2009</year>
<volume>132</volume>
<issue>Pt 3</issue>
<fpage>810</fpage>
<lpage>819</lpage>
<pub-id pub-id-type="doi">10.1093/brain/awn366</pub-id>
<pub-id pub-id-type="pmid">19201763</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stogmann</surname>
<given-names>E</given-names>
</name>
<name>
<surname>El Tawil</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wagenstaller</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gaber</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Edris</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Abdelhady</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A novel mutation in the MFSD8 gene in late infantile neuronal ceroid lipofuscinosis</article-title>
<source/>Neurogenetics
          <year>2009</year>
<volume>10</volume>
<issue>1</issue>
<fpage>73</fpage>
<lpage>77</lpage>
<pub-id pub-id-type="doi">10.1007/s10048-008-0153-1</pub-id>
<pub-id pub-id-type="pmid">18850119</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siintola</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Topcu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kohlschütter</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Salonen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Joensuu</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Anttonen</surname>
<given-names>AK</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Two novel CLN6 mutations in variant late-infantile neuronal ceroid lipofuscinosis patients of Turkish origin</article-title>
<source/>Clin Genet
          <year>2005</year>
<volume>68</volume>
<issue>2</issue>
<fpage>167</fpage>
<lpage>173</lpage>
<pub-id pub-id-type="doi">10.1111/j.1399-0004.2005.00471.x</pub-id>
<pub-id pub-id-type="pmid">15996215</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ranta</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Topcu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tegelberg</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ustübütün</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Saatci</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Variant late infantile neuronal ceroid lipofuscinosis in a subset of Turkish patients is allelic to northern epilepsy</article-title>
<source/>Hum Mutat
          <year>2004</year>
<volume>23</volume>
<issue>4</issue>
<fpage>300</fpage>
<lpage>305</lpage>
<pub-id pub-id-type="doi">10.1002/humu.20018</pub-id>
<pub-id pub-id-type="pmid">15024724</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mandel</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Cohen Katsanelson</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Khayat</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chervinsky</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Vladovski</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Iancu</surname>
<given-names>TC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clinico-pathological manifestations of variant late infantile neuronal ceroid lipofuscinosis (vLINCL) caused by a novel mutation in MFSD8 gene</article-title>
<source/>Eur J Med Genet
          <year>2014</year>
<volume>57</volume>
<issue>11–12</issue>
<fpage>607</fpage>
<lpage>612</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejmg.2014.09.004</pub-id>
<pub-id pub-id-type="pmid">25270050</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Craiu</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Dragostin</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Dica</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hoffman-Zacharska</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Gos</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bastian</surname>
<given-names>AE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Rett-like onset in late-infantile neuronal ceroid lipofuscinosis (CLN7) caused by compound heterozygous mutation in the MFSD8 gene and review of the literature data on clinical onset signs</article-title>
<source/>Eur J Paediatr Neurol
          <year>2015</year>
<volume>19</volume>
<issue>1</issue>
<fpage>78</fpage>
<lpage>86</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejpn.2014.07.008</pub-id>
<pub-id pub-id-type="pmid">25439737</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Santavuori</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Haltia</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rapola</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Infantile type of so-called neuronal ceroid-lipofuscinosis</article-title>
<source/>Dev Med Child Neurol
          <year>1974</year>
<volume>16</volume>
<issue>5</issue>
<fpage>644</fpage>
<lpage>653</lpage>
<pub-id pub-id-type="doi">10.1111/j.1469-8749.1974.tb04183.x</pub-id>
<pub-id pub-id-type="pmid">4371326</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Inoue</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Xing</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kushima</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Egawa</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Okuda</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Resequencing and association analysis of <italic>CLN8</italic> with autism Spectrum disorder in a Japanese population</article-title>
<source/>PLoS One
          <year>2015</year>
<volume>10</volume>
<issue>12</issue>
<fpage>e0144624</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0144624</pub-id>
<pub-id pub-id-type="pmid">26657971</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valadares</surname>
<given-names>ER</given-names>
</name>
<name>
<surname>Pizarro</surname>
<given-names>MX</given-names>
</name>
<name>
<surname>Oliveira</surname>
<given-names>LR</given-names>
</name>
<name>
<surname>Caldas de Amorim</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Magalhães Pinheiro</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Grieben</surname>
<given-names>U</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Juvenile neuronal ceroid-lipofuscinosis: clinical and molecular investigation in a large family in Brazil</article-title>
<source/>Arq Neuropsiquiatr
          <year>2011</year>
<volume>69</volume>
<issue>1</issue>
<fpage>13</fpage>
<lpage>18</lpage>
<pub-id pub-id-type="doi">10.1590/S0004-282X2011000100004</pub-id>
<pub-id pub-id-type="pmid">21359416</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martin</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Cutadapt removes adapter sequences from high-throughput sequencing reads</article-title>
<source/>EMBnetjournal
          <year>2011</year>
<volume>17</volume>
<fpage>10</fpage>
<lpage>12</lpage>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Durbin</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Fast and accurate short read alignment with burrows-wheeler transform</article-title>
<source/>Bioinformatics
          <year>2009</year>
<volume>25</volume>
<issue>14</issue>
<fpage>1754</fpage>
<lpage>1760</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btp324</pub-id>
<pub-id pub-id-type="pmid">19451168</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<mixed-citation publication-type="other">FastQC: a quality control tool for high throughput sequence data. <ext-link ext-link-type="uri" xlink:href="https://www.bioinformatics.babraham.ac.uk/projects/fastqc/">https://www.bioinformatics.babraham.ac.uk/projects/fastqc/</ext-link>. Accessed 1 June 2018.</mixed-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McKenna</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hanna</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Banks</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Sivachenko</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Cibulskis</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kernytsky</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data</article-title>
<source/>Genome Res
          <year>2010</year>
<volume>20</volume>
<issue>9</issue>
<fpage>1297</fpage>
<lpage>1303</lpage>
<pub-id pub-id-type="doi">10.1101/gr.107524.110</pub-id>
<pub-id pub-id-type="pmid">20644199</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>DePristo</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Banks</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Poplin</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Garimella</surname>
<given-names>KV</given-names>
</name>
<name>
<surname>Maguire</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Hartl</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A framework for variation discovery and genotyping using next-generation DNA sequencing data</article-title>
<source/>Nat Genet
          <year>2011</year>
<volume>43</volume>
<issue>5</issue>
<fpage>491</fpage>
<lpage>498</lpage>
<pub-id pub-id-type="doi">10.1038/ng.806</pub-id>
<pub-id pub-id-type="pmid">21478889</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van der Auwera</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Carneiro</surname>
<given-names>MO</given-names>
</name>
<name>
<surname>Hartl</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Poplin</surname>
<given-names>R</given-names>
</name>
<name>
<surname>del Angel</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Levy-Moonshine</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline</article-title>
<source/>Curr Protoc Bioinformatics
          <year>2013</year>
<volume>11</volume>
<issue>1110</issue>
<fpage>11.10.1</fpage>
<lpage>11.10.33</lpage>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cingolani</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Platts</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>LL</given-names>
</name>
<name>
<surname>Coon</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3</article-title>
<source/>Fly (Austin)
          <year>2012</year>
<volume>6</volume>
<issue>2</issue>
<fpage>80</fpage>
<lpage>92</lpage>
<pub-id pub-id-type="doi">10.4161/fly.19695</pub-id>
<pub-id pub-id-type="pmid">22728672</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Boerwinkle</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>dbNSFP v3.0: a one-stop database of functional predictions and annotations for human non-synonymous and splice site SNVs</article-title>
<source/>Hum Mutat
          <year>2016</year>
<volume>37</volume>
<issue>3</issue>
<fpage>235</fpage>
<lpage>241</lpage>
<pub-id pub-id-type="doi">10.1002/humu.22932</pub-id>
<pub-id pub-id-type="pmid">26555599</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<mixed-citation publication-type="other">ClinVar. <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/clinvar/">http://www.ncbi.nlm.nih.gov/clinvar/</ext-link>. Accessed 1 June 2018.</mixed-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Landrum</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Benson</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Chao</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Chitipiralla</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>ClinVar: public archive of interpretations of clinically relevant variants</article-title>
<source/>Nucleic Acids Res
          <year>2016</year>
<volume>44</volume>
<issue>Database issue</issue>
<fpage>D862</fpage>
<lpage>D868</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkv1222</pub-id>
<pub-id pub-id-type="pmid">26582918</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<mixed-citation publication-type="other">OMIM database (Online Mendelian Inheritance in Man). <ext-link ext-link-type="uri" xlink:href="https://omim.org/">https://omim.org/</ext-link>. Accessed 1 June 2018.</mixed-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<mixed-citation publication-type="other">The Human Gene Mutation Database <ext-link ext-link-type="uri" xlink:href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=CTNS">http://www.hgmd.cf.ac.uk/ac/gene.php?gene=CTNS</ext-link>. Accessed 1 June 2018.</mixed-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ng</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Henikoff</surname>
<given-names>SSIFT</given-names>
</name>
</person-group>
<article-title>Predicting amino acid changes that affect protein function</article-title>
<source/>Nucleic Acids Res
          <year>2003</year>
<volume>31</volume>
<issue>13</issue>
<fpage>3812</fpage>
<lpage>3814</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkg509</pub-id>
<pub-id pub-id-type="pmid">12824425</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<mixed-citation publication-type="other">PolyPhen-2 (Polymorphism Phenotyping v2). <ext-link ext-link-type="uri" xlink:href="http://genetics.bwh.harvard.edu/pph2/">http://genetics.bwh.harvard.edu/pph2/</ext-link>. Accessed 1 June 2018.</mixed-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<mixed-citation publication-type="other">Adzhubei I, Jordan DM, Sunyaev SR. Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet 2013;Chapter 7:Unit7.20. doi: 10.1002/0471142905.hg0720s76.</mixed-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<mixed-citation publication-type="other">1000Genomes project. <ext-link ext-link-type="uri" xlink:href="http://browser.1000genomes.org/index.html">http://browser.1000genomes.org/index.html</ext-link>. Accessed 1 June 2018.</mixed-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>1000 Genomes Project Consortium</collab>
<name>
<surname>Auton</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Brooks</surname>
<given-names>LD</given-names>
</name>
<name>
<surname>Durbin</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Garrison</surname>
<given-names>EP</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>HM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A global reference for human genetic variation</article-title>
<source/>Nature
          <year>2015</year>
<volume>526</volume>
<issue>7571</issue>
<fpage>68</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="doi">10.1038/nature15393</pub-id>
<pub-id pub-id-type="pmid">26432245</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<mixed-citation publication-type="other">ExAC (Exome Aggregation Consortium). <ext-link ext-link-type="uri" xlink:href="http://exac.broadinstitute.org/">http://exac.broadinstitute.org/</ext-link>. Accessed 1 June 2018.</mixed-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lek</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Karczewski</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Minikel</surname>
<given-names>EV</given-names>
</name>
<name>
<surname>Samocha</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Banks</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Fennell</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Analysis of protein-coding genetic variation in 60,706 humans</article-title>
<source/>Nature
          <year>2016</year>
<volume>536</volume>
<issue>7616</issue>
<fpage>285</fpage>
<lpage>291</lpage>
<pub-id pub-id-type="doi">10.1038/nature19057</pub-id>
<pub-id pub-id-type="pmid">27535533</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Richards</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Aziz</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Bale</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bick</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gastier-Foster</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology</article-title>
<source/>Genet Med
          <year>2015</year>
<volume>17</volume>
<issue>5</issue>
<fpage>405</fpage>
<lpage>423</lpage>
<pub-id pub-id-type="doi">10.1038/gim.2015.30</pub-id>
<pub-id pub-id-type="pmid">25741868</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Talevich</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Shain</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Botton</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Bastian</surname>
<given-names>BCCNV</given-names>
</name>
</person-group>
<article-title>Genome-wide copy number detection and visualization from targeted sequencing</article-title>
<source/>PLoS Comput Biol
          <year>2014</year>
<volume>12</volume>
<issue>4</issue>
<fpage>e1004873</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pcbi.1004873</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hentze</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>Kulozik</surname>
<given-names>AE</given-names>
</name>
</person-group>
<article-title>A perfect message: RNA surveillance and nonsense-mediated decay</article-title>
<source/>Cell
          <year>1999</year>
<volume>96</volume>
<issue>3</issue>
<fpage>307</fpage>
<lpage>310</lpage>
<pub-id pub-id-type="doi">10.1016/S0092-8674(00)80542-5</pub-id>
<pub-id pub-id-type="pmid">10025395</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aiello</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Terracciano</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Simonati</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Discepoli</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Cannelli</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Claps</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutations in MFSD8/CLN7 are a frequent cause of variant-late infantile neuronal ceroid lipofuscinosis</article-title>
<source/>Hum Mutat
          <year>2009</year>
<volume>30</volume>
<issue>3</issue>
<fpage>E530</fpage>
<lpage>E540</lpage>
<pub-id pub-id-type="doi">10.1002/humu.20975</pub-id>
<pub-id pub-id-type="pmid">19177532</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pao</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Paulsen</surname>
<given-names>IT</given-names>
</name>
<name>
<surname>Saier</surname>
<given-names>MH</given-names>
<suffix>Jr</suffix>
</name>
</person-group>
<article-title>Major facilitator superfamily</article-title>
<source/>Microbiol Mol Biol Rev
          <year>1998</year>
<volume>62</volume>
<issue>1</issue>
<fpage>1</fpage>
<lpage>34</lpage>
<pub-id pub-id-type="pmid">9529885</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharifi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kousi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sagné</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bellenchi</surname>
<given-names>GC</given-names>
</name>
<name>
<surname>Morel</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Darmon</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Expression and lysosomal targeting of CLN7, a major facilitator superfamily transporter associated with variant late-infantile neuronal ceroid lipofuscinosis</article-title>
<source/>Hum Mol Genet
          <year>2010</year>
<volume>19</volume>
<issue>22</issue>
<fpage>4497</fpage>
<lpage>4514</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddq381</pub-id>
<pub-id pub-id-type="pmid">20826447</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>